Skip to content

CORMEDIX INC.: 10-Q filed 2019-11-14

What CORMEDIX INC. reported in its quarterly report filed 2019-11-14 (fiscal Q3 2019): 40 published measures, 105 facts as tagged in accession 0001213900-19-023505.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-14
Fiscal period
fiscal Q3 2019
Accession
0001213900-19-023505 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORMEDIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-3033,717,463USD
At 2018-12-3118,825,914USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-09-305,009,688USD
At 2018-12-3113,891,658USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-3028,707,775USD
At 2019-06-3016,475,051USD
At 2018-12-314,934,256USD
At 2018-09-30-9,497,574USD
At 2018-06-30-6,478,017USD
At 2017-12-317,193,351USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-3020,145,052USD
At 2018-12-3117,623,770USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-5,264,847USD92
2019-01-01 to 2019-09-30-11,128,889USD273
2018-07-01 to 2018-09-30-10,236,119USD92
2018-01-01 to 2018-09-30-28,978,147USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-11,167,318USD273
2018-01-01 to 2018-09-30-16,500,414USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-09-3027,142USD273
2018-01-01 to 2018-09-3048,893USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-07-01 to 2019-09-3059,530USD92
2019-01-01 to 2019-09-30258,488USD273
2018-07-01 to 2018-09-30372,514USD92
2018-01-01 to 2018-09-30403,274USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-3026,010,291USD273
2018-01-01 to 2018-09-3011,012,647USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-12,316,718USD273
2018-01-01 to 2018-09-301,555,305USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-190,116,987USD
At 2018-12-31-178,988,098USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-5,060,778USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-09-30134,515USD
At 2018-12-31160,860USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-09-301,986,274USD273
2018-01-01 to 2018-09-301,091,613USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-5,171,515USD92
2019-01-01 to 2019-09-30-15,632,052USD273
2018-07-01 to 2018-09-30-10,241,453USD92
2018-01-01 to 2018-09-30-29,002,427USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-3033,582,948USD
At 2018-12-3118,665,054USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-07-01 to 2019-09-30172,429USD92
2019-01-01 to 2019-09-30781,212USD273
2018-01-01 to 2018-09-301,873USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-305,006,600USD
At 2018-12-317,766,230USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-09-301,054,971USD
At 2018-12-312,588,977USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-305,152,019USD92
2019-01-01 to 2019-09-3015,563,431USD273
2018-07-01 to 2018-09-3010,301,533USD92
2018-01-01 to 2018-09-3029,031,029USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-09-30381,065USD
At 2018-12-31428,515USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-19,496USD92
2019-01-01 to 2019-09-30-68,621USD273
2018-07-01 to 2018-09-3060,080USD92
2018-01-01 to 2018-09-3028,602USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-07-01 to 2019-09-3079,026USD92
2019-01-01 to 2019-09-30327,109USD273
2018-07-01 to 2018-09-30312,434USD92
2018-01-01 to 2018-09-30374,672USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-07-01 to 2019-09-302,631,027USD92
2019-01-01 to 2019-09-307,187,535USD273
2018-07-01 to 2018-09-302,012,439USD92
2018-01-01 to 2018-09-305,861,279USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-07-01 to 2019-09-302,520,992USD92
2019-01-01 to 2019-09-308,375,896USD273
2018-07-01 to 2018-09-308,289,094USD92
2018-01-01 to 2018-09-3023,169,750USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-3025,650,429shares
At 2018-12-3121,775,173shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2019-09-3020,315,346USD
At 2018-12-3117,795,323USD
At 2018-09-306,615,421USD
At 2017-12-3110,551,282USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-09-306,000USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-09-30102,001USD
At 2018-12-3196,522USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-09-305,000USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-09-305,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-09-303,947,218USD
At 2018-12-315,166,224USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-09-30526,684USD
At 2018-12-31422,199USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-5,264,847USD92
2019-01-01 to 2019-09-30-16,189,667USD273
2018-07-01 to 2018-09-30-10,236,119USD92
2018-01-01 to 2018-09-30-28,978,147USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-5,267,186USD92
2019-01-01 to 2019-09-30-11,123,410USD273
2018-07-01 to 2018-09-30-10,242,524USD92
2018-01-01 to 2018-09-30-28,985,582USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-32,367,445USD92
2019-01-01 to 2019-09-30-38,231,487USD273
2018-07-01 to 2018-09-30-10,236,119USD92
2018-01-01 to 2018-09-30-28,978,147USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-09-3056,568USD273
2018-01-01 to 2018-09-3056,791USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-6,634USD273
2018-01-01 to 2018-09-30247,317USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-45,010USD273
2018-01-01 to 2018-09-30-253,017USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-1,533,649USD273
2018-01-01 to 2018-09-306,074,905USD273

Inspect the source

Entity
CORMEDIX INC. / CIK 0001410098
Captured
2026-09-20T08:01:45.168Z
SEC response SHA-256
b75757faacc84388fbe591a3ec2593969ffefe3c9ea86056a188a6fcb0c2f8bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001410098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))